LOS ANGELES CAPITAL MANAGEMENT LLC

Position in GH — Guardant Health, Inc.

CIK 1177206 LOS ANGELES, CA

Position in GH

as of Jun 30, 2026 · filed Aug 13, 2026 Compact

Position Value

$536,807

-$457,648 QoQ

Shares Held

3,578

-66.8% QoQ

Ownership

0.003%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#364

of 596 holders

Holding Since

Jun 2020

13 quarters on record

Voting authority Sole 17% Shared 0% None 83%

Healthcare · as of Jun 30, 2026

LOS ANGELES CAPITAL MANAGEMENT LLC holds $124,186,888 across 28 Diagnostics & Research names. GH ranks #8 (0.4% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	A	Agilent Technologies, Inc.	477,841	$63,471,620
2	IQV	Iqvia Holdings Inc.	131,127	$25,336,358
3	NTRA	Natera, Inc.	48,046	$13,042,086
4	IDXX	Idexx Laboratories Inc /De	17,602	$9,266,396
5	MEDP	Medpace Holdings, Inc.	10,200	$5,401,818
6	VCYT	Veracyte, Inc.	69,585	$4,086,727
7	TMO	Thermo Fisher Scientific Inc.	1,631	$817,718
8	GH	Guardant Health, Inc. This page	3,578	$536,807

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$536,807	3,578	-66.8%	Shares	Sole	2026-08-13
2026-03-31	$994,455	10,766	+17.9%	Shares	Sole	2026-05-08
2025-12-31	$932,538	9,130	-38.3%	Shares	Sole	2026-02-11
2023-12-31	$400,150	14,793	+27.8%	Shares	Sole	2024-02-06
2023-09-30	$343,083	11,575	-27.0%	Shares	Sole	2023-11-06
2023-06-30	$567,788	15,860	+628.2%	Shares	Sole	2023-08-03
2021-12-31	$217,843	2,178	-4.8%	Shares	Sole	2022-02-03
2021-09-30	$286,022	2,288	-32.0%	Shares	Sole	2021-11-08
2021-06-30	$417,650	3,363	0.0%	Shares	Sole	2021-08-05
2021-03-31	$513,361	3,363	-22.6%	Shares	Sole	2021-05-05
2020-12-31	$559,725	4,343	+58.8%	Shares	Sole	2021-03-10
2020-09-30	$305,718	2,735	+7.0%	Shares	Sole	2020-11-02
2020-06-30	$207,287	2,555	—	Shares	Sole	2020-08-05
No filing history on record for this holder in this stock.